21
https://pubmed.ncbi.nlm.nih.gov/38112997
RNA modifications, particularly N6-methyladenosine, play crucial roles in cancer metabolic reprogramming and shaping the tumor microenvironment, and targeting these modifications shows promise as a therapeutic approach for anti-tumor treatment.
